Brigham Buhler

It shouldn't be. That's the point. They're getting money on every drug that you're prescribed. Imagine the amount of revenue being generated by these insurance companies by screwing me and you and families on these medications.

I mean, it definitely seems to be a common problem. Like, if we look at what the U.S. spends in healthcare, you know, we're number one in healthcare costs, but I think 60th overall in our overall health. You know, I mean, it's pretty bad. And the most recent statistics are, you know, 70 percent, 67 percent of adults are overweight. I mean, which is staggering. Yeah.

I mean, it definitely seems to be a common problem. Like, if we look at what the U.S. spends in healthcare, you know, we're number one in healthcare costs, but I think 60th overall in our overall health. You know, I mean, it's pretty bad. And the most recent statistics are, you know, 70 percent, 67 percent of adults are overweight. I mean, which is staggering. Yeah.

I mean, it definitely seems to be a common problem. Like, if we look at what the U.S. spends in healthcare, you know, we're number one in healthcare costs, but I think 60th overall in our overall health. You know, I mean, it's pretty bad. And the most recent statistics are, you know, 70 percent, 67 percent of adults are overweight. I mean, which is staggering. Yeah.

13 to 19 age demographic, though our children are over 30 percent are on the cusp of prediabetes. Like it's I mean, we're just chronically ill as a society. The system's definitely letting individuals, families, all of us down.

13 to 19 age demographic, though our children are over 30 percent are on the cusp of prediabetes. Like it's I mean, we're just chronically ill as a society. The system's definitely letting individuals, families, all of us down.

13 to 19 age demographic, though our children are over 30 percent are on the cusp of prediabetes. Like it's I mean, we're just chronically ill as a society. The system's definitely letting individuals, families, all of us down.

Yeah, the average American's on four or more medications, four or more prescription medications.

Yeah, the average American's on four or more medications, four or more prescription medications.

Yeah, the average American's on four or more medications, four or more prescription medications.

It's way higher than the rest of the world. And we also fit the bill for most of the innovation of healthcare, which is a problem in itself because so many people go, well, meds are expensive in America because we fund the innovation. Most of the innovation is funded through taxpayer dollars via the NIH. A lot of people don't understand that. So we're fitting the bill

It's way higher than the rest of the world. And we also fit the bill for most of the innovation of healthcare, which is a problem in itself because so many people go, well, meds are expensive in America because we fund the innovation. Most of the innovation is funded through taxpayer dollars via the NIH. A lot of people don't understand that. So we're fitting the bill

It's way higher than the rest of the world. And we also fit the bill for most of the innovation of healthcare, which is a problem in itself because so many people go, well, meds are expensive in America because we fund the innovation. Most of the innovation is funded through taxpayer dollars via the NIH. A lot of people don't understand that. So we're fitting the bill

to identify compounds that are promising for driving health span and preventing chronic disease and all these things is where the money should be applied. But instead, our money is getting applied towards treating symptomology. And so the NIH is looking at studies that are driven by who? Big Pharma. And Big Pharma asked the NIH, look at these compounds.

to identify compounds that are promising for driving health span and preventing chronic disease and all these things is where the money should be applied. But instead, our money is getting applied towards treating symptomology. And so the NIH is looking at studies that are driven by who? Big Pharma. And Big Pharma asked the NIH, look at these compounds.

to identify compounds that are promising for driving health span and preventing chronic disease and all these things is where the money should be applied. But instead, our money is getting applied towards treating symptomology. And so the NIH is looking at studies that are driven by who? Big Pharma. And Big Pharma asked the NIH, look at these compounds.

And when a compound gets close enough to a point where they think they can patent it and monetize it, the NIH just hands the molecule over for pennies on the dollar to Big Pharma, where they then put it through a double blind placebo controlled trial, if we're lucky, and push it into the marketplace and patent it.

And when a compound gets close enough to a point where they think they can patent it and monetize it, the NIH just hands the molecule over for pennies on the dollar to Big Pharma, where they then put it through a double blind placebo controlled trial, if we're lucky, and push it into the marketplace and patent it.

And when a compound gets close enough to a point where they think they can patent it and monetize it, the NIH just hands the molecule over for pennies on the dollar to Big Pharma, where they then put it through a double blind placebo controlled trial, if we're lucky, and push it into the marketplace and patent it.

And so we, the American people, are paying the bill for these innovations multiple times. We funded the original legwork to get this molecule to a point it could be patented. Then the NIH turns it over to Big Pharma. Then Big Pharma patents it and we got to pay for it again.